Author

Meganathan Nandakumar

University of North Carolina at Chapel HillORCID 0000-0002-9093-2244Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Timothy Mark WillsoniD· 2 shared Anand G. ValaiD· 1 shared Angie L. MordantiD· 1 shared Anirban GhoshaliD· 1 shared Aurora CabreraiD· 1 shared Bonnie YiuiD· 1 shared David Harold DrewryiD· 1 shared David J. ShirleyiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Timothy Mark WillsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJan 10, 2025

Chemoproteomic Profiling of C. albicans for Characterization of Anti-fungal Kinase Inhibitors

David J. Shirley, Meganathan Nandakumar, Aurora Cabrera…·Timothy Mark Willson

The paper uses chemoproteomic profiling to identify selective anti-fungal kinase inhibitors targeting C. albicans CK1 homologs.

DOI 10.1101/2025.01.10.632200

C. elegansproteomics

𝕏 PostBluesky

Cell BiologyJournal of Medicinal ChemistryPeer-reviewedSep 5, 2024

Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of Chikungunya nsP2 Cysteine Protease with Anti-alphavirus Activity

Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain…·Timothy Mark Willson

The paper identifies potent covalent inhibitors of Chikungunya nsP2 protease and establishes structure-activity relationships to guide inhibitor design.

30 citationstop 1%

experimental assaydrug response / drug discovery

𝕏 PostBluesky